Magdalena Lipczyńska

Magdalena Lipczyńska

Auto-generated profile, based on publicly available information

Magdalena Lipczyńska

Department of Congenital Cardiac Defects, Institute of Cardiology, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
MLMagdalena Lipczyńska
Magdalena Lipczyńska
PSPiotr Szymański
Piotr Szymański
MKMagdalena Kumor
Magdalena Kumor
AKAnna Klisiewicz
Anna Klisiewicz
ŁMŁukasz Mazurkiewicz
Łukasz Mazurkiewicz
PHPiotr Hoffman
Piotr Hoffman

1 February 2011 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
MLMagdalena Lipczyńska
Magdalena Lipczyńska
PSPiotr Szymański
Piotr Szymański
AKAnna Klisiewicz
Anna Klisiewicz
PHPiotr Hoffman
Piotr Hoffman

2 August 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MLMagdalena Lipczyńska
Magdalena Lipczyńska
PSPiotr Szymański
Piotr Szymański
MKMagdalena Kumor
Magdalena Kumor
AKAnna Klisiewicz
Anna Klisiewicz
PHPiotr Hoffman
Piotr Hoffman
Myocardial fibrosis is a potential pathophysiological mechanism leading to systemic right ventricular (SRV) deterioration. We hypothesize that circulating levels of collagen deposition markers are elevated in patients with SRV remodeling and this elevation may have a predictive value. We prospectively evaluated 56 patients with D-TGA after the atrial switch procedure (mean age 25.6 ± 4.8, range 18–37 years; 67% males). Serum levels of procollagen type III amino-terminal propeptide (PIIINP), collagen type I carboxy-terminal telopeptide (CITP), procollagen type I N-terminal propeptide (PINP), matrix metalloproteinase (MMP 1, MMP 9) and a tissue inhibitor of matrix metalloproteinase (TIMP 1) and N-terminal pro-brain natriuretic peptide (NT-pro-BNP) were measured and compared with healthy controls. The relationship between these serum markers, echocardiographic and cardiac magnetic resonance parameters and the outcome at a follow-up of 61 months (range, 24–85 months) was determined. Compared with the healthy control group, the study group had significantly higher levels of TIMP1, PIIINP, CITP, PINP and NT-pro-BNP (p<0.05, each). The levels of PIIINP and CITP were significantly higher among patients with an SRV mass index above the mean value. The level of PIIINP was significantly higher among patients with an SRV EDV index above the mean value. CITP was significantly elevated in SRV late gadolinium enhanced (LGE) positive patients, compared to patients without SRV LGE. MMP9 and TIMP1 predicted an adverse clinical outcome on univariate Cox proportional hazard survival analysis in addition to well proven predictors of outcome (SRV EF and NYHA). We demonstrated a pattern of altered collagen turnover adversely related with the indices of SRV remodeling and an adverse clinical outcome in patients with SRV.

1 February 2009 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
PHPiotr Hoffman
Piotr Hoffman
PSPiotr Szymański
Piotr Szymański
BLBarbara Lubiszewska
Barbara Lubiszewska
JRJacek Różański
Jacek Różański
MLMagdalena Lipczyńska
Magdalena Lipczyńska
Cezary ZekanowskiCezary Zekanowski
Cezary Zekanowski

7 January 2010 in International Journal of Cardiology
Verified
Journal Article
Closed access
PSPiotr Szymański
Piotr Szymański
AKAnna Klisiewicz
Anna Klisiewicz
BLBarbara Lubiszewska
Barbara Lubiszewska
JJJadwiga Janas
Jadwiga Janas
KBKatarzyna Barańska
Katarzyna Barańska
PHPiotr Hoffman
Piotr Hoffman

5 May 2016 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
MLMagdalena Lipczyńska
Magdalena Lipczyńska
PSPiotr Szymański
Piotr Szymański
OTOlga Trojnarska
Olga Trojnarska
LTLidia Tomkiewicz-Pająk
Lidia Tomkiewicz-Pająk
BPBronisława Pietrzak
Bronisława Pietrzak
PHPiotr Hoffman
Piotr Hoffman
Objective: We sought to identify maternal/neonatal and cardiovascular complications in pregnant women with complete transposition of great arteries (D-TGA) following atrial switch. Methods: Clinical records of all women with D-TGA after the Mustard/Senning (M/S) operation who were followed at the three largest Adult Congenital Heart Disease (ACHD) centers in Poland were reviewed. Results: Fifteen of the fifty-nine women followed had a total of 24 pregnancies, including two spontaneous miscarriages. Twenty-two pregnancies (92%) resulted in a live birth, 91% were by cesarean section. During 5 (23%) of the 22 completed pregnancies obstetric complications were observed (one gestational diabetes, one hypertension in pregnancy, one placenta increta and two preterm labors). The mean pregnancy duration was 37.2 weeks (range: 26–41 weeks).We observed one neonatal death due to extreme prematurity. Six (25%) children had a birth weight of ≤2500 g. None of women had severe cardiac complications during pregnancy nor in the postpartum period. Conclusions: In our study, we demonstrated a large number of obstetric complications and low birth weight in the presence of a systemic right ventricle. However, from a cardiologist’s point of view pregnancy after the M/S operation was well-tolerated and relatively safe.